Cycclone Inc., together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, the company engages in residential and commercial real estate investment. The company was formerly known as China Dasheng Biotechnology Co. and changed its name to Cycclone Inc. in May 2025. Cycclone Inc. was founded in 2004 and is based in Lanzhou, China.
Frequently asked questions
What sector does China Dasheng Biotechnology Company (CDBT) operate in?
China Dasheng Biotechnology Company belongs to the Financials sector and operates in the Shell Companies industry.
What is China Dasheng Biotechnology Company (CDBT) current stock price?
As of the latest data, China Dasheng Biotechnology Company stock price is $0.04, with a previous close of $0.03. China Dasheng Biotechnology Company gained $0.01 in the last trading session, representing a 37.22% increase.
What is China Dasheng Biotechnology Company (CDBT) current market capitalization?
China Dasheng Biotechnology Company market cap is approximately 1.74 million.
What is China Dasheng Biotechnology Company (CDBT) Earnings Per Share (EPS)?
The trailing EPS is -$0.02.
Does China Dasheng Biotechnology Company (CDBT) pay dividends?
No. China Dasheng Biotechnology Company does not pay a dividend.
What is China Dasheng Biotechnology Company (CDBT) beta (volatility) score?
China Dasheng Biotechnology Company has a beta of 2.256, indicating very high volatility compared to the market.